Clinical Trial Update: A Prospective, Multi-site Clinical Study to Collect User Feedback Using Affirm® Contrast Biopsy [NA]

View source ↗

Summary

A completed multi-site clinical study collecting user feedback on Affirm Contrast Biopsy in breast cancer patients; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Affirm Contrast Biopsy

Snippet

Sponsor: Hologic, Inc. | Conditions: Breast Cancer | NA | Status: COMPLETED | Results posted: 2023-10-05